196 related articles for article (PubMed ID: 37374257)
1. Effects of Intravitreal Ranibizumab Injection on Peripheral Retinal Microcirculation and Cytokines in Branch Retinal Vein Occlusion with Macular Edema.
Yasuda K; Noma H; Mimura T; Nonaka R; Sasaki S; Suganuma N; Shimura M
Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374257
[No Abstract] [Full Text] [Related]
2. Retinal Microcirculation and Cytokines as Predictors for Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Branch Retinal Vein Occlusion.
Noma H; Yasuda K; Mimura T; Suganuma N; Shimura M
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375281
[TBL] [Abstract][Full Text] [Related]
3. Change of cytokines after intravitreal ranibizumab in patients with recurrent branch retinal vein occlusion and macular edema.
Noma H; Yasuda K; Shimura M
Eur J Ophthalmol; 2021 Jan; 31(1):204-210. PubMed ID: 31690095
[TBL] [Abstract][Full Text] [Related]
4. Effects of ranibizumab on growth factors and mediators of inflammation in the aqueous humor of patients with diabetic macular edema.
Utsumi T; Noma H; Yasuda K; Goto H; Shimura M
Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2597-2603. PubMed ID: 33772356
[TBL] [Abstract][Full Text] [Related]
5. Changes in Retinal Microcirculation After Intravitreal Ranibizumab Injection in Eyes With Macular Edema Secondary to Branch Retinal Vein Occlusion.
Fukami M; Iwase T; Yamamoto K; Kaneko H; Yasuda S; Terasaki H
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1246-1255. PubMed ID: 28241312
[TBL] [Abstract][Full Text] [Related]
6. RELATIONSHIP BETWEEN CHOROIDAL FINDINGS AND GROWTH FACTORS, CYTOKINES, AND OTHER INFLAMMATORY MEDIATORS AFTER INTRAVITREAL RANIBIZUMAB INJECTION IN PATIENTS WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION.
Noma H; Yasuda K; Mimura T; Shimura M
Retina; 2022 Apr; 42(4):744-751. PubMed ID: 35350049
[TBL] [Abstract][Full Text] [Related]
7. Anti-Vascular Endothelial Growth Factor Therapy with or Without Initial Steroid Therapy for Macular Edema in Branch Retinal Vein Occlusion.
Noma H; Yasuda K; Nonaka R; Sasaki S; Shimura M
Clin Ophthalmol; 2023; 17():2267-2275. PubMed ID: 37581097
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.
Noma H; Mimura T; Yasuda K; Shimura M
Ophthalmic Res; 2016; 56(4):207-214. PubMed ID: 27160159
[TBL] [Abstract][Full Text] [Related]
9. Functional-morphological parameters, aqueous flare and cytokines in macular oedema with branch retinal vein occlusion after ranibizumab.
Noma H; Mimura T; Yasuda K; Shimura M
Br J Ophthalmol; 2017 Feb; 101(2):180-185. PubMed ID: 27073207
[TBL] [Abstract][Full Text] [Related]
10. POSSIBLE MOLECULAR BASIS OF BEVACIZUMAB THERAPY FOR MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION.
Noma H; Mimura T; Yasuda K; Shimura M
Retina; 2016 Sep; 36(9):1718-25. PubMed ID: 26866529
[TBL] [Abstract][Full Text] [Related]
11. Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema.
Noma H; Mimura T; Yasuda K; Shimura M
Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3878-85. PubMed ID: 24894397
[TBL] [Abstract][Full Text] [Related]
12. Effects of Intravitreal Ranibizumab Injection to Treat Macular Edema due to Central Retinal Vein Occlusion on Choroidal Findings and Functional-Morphological Parameters.
Yasuda K; Noma H; Oyama E; Yanagida K; Asakage M; Shimura M
Ophthalmic Res; 2023; 66(1):1063-1070. PubMed ID: 37331343
[TBL] [Abstract][Full Text] [Related]
13. Role of Cytokines in Ranibizumab Therapy for Macular Edema in Patients with Central Retinal Vein Occlusion.
Matsushima R; Noma H; Yasuda K; Goto H; Shimura M
J Ocul Pharmacol Ther; 2019 Sep; 35(7):407-412. PubMed ID: 31373873
[No Abstract] [Full Text] [Related]
14. Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case series.
Noma H; Yasuda K; Minezaki T; Watarai S; Shimura M
BMC Ophthalmol; 2016 May; 16():61. PubMed ID: 27225268
[TBL] [Abstract][Full Text] [Related]
15. Relationship between retinal blood flow and cytokines in central retinal vein occlusion.
Noma H; Yasuda K; Mimura T; Ofusa A; Shimura M
BMC Ophthalmol; 2020 Jun; 20(1):215. PubMed ID: 32503534
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal Ranibizumab and Aqueous Humor Factors/Cytokines in Major and Macular Branch Retinal Vein Occlusion.
Noma H; Mimura T; Yasuda K; Nakagawa H; Motohashi R; Kotake O; Shimura M
Ophthalmologica; 2016; 235(4):203-7. PubMed ID: 27003517
[TBL] [Abstract][Full Text] [Related]
17. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
Sohn HJ; Han DH; Lee DY; Nam DH
Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.
Lim JW
Ophthalmologica; 2011; 225(3):150-4. PubMed ID: 21150231
[TBL] [Abstract][Full Text] [Related]
19. Cytokines and Recurrence of Macular Edema after Intravitreal Ranibizumab in Patients with Branch Retinal Vein Occlusion.
Noma H; Mimura T; Yasuda K; Nakagawa H; Motohashi R; Kotake O; Shimura M
Ophthalmologica; 2016; 236(4):228-234. PubMed ID: 27832655
[TBL] [Abstract][Full Text] [Related]
20. The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema resulting from retinal vein occlusion.
Yong H; Qi H; Yan H; Wu Q; Zuo L
Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3243-3250. PubMed ID: 34059950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
